American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Open accessThe DOI matches its Crossref record; 166 of the 171 references it cites were found in a registry or an index.
Abstract
Does inpatient management of hyperglycemia represent a safety concern? 5. What systems need to be in place to achieve these recommendations?6.Is treatment of inpatient hyperglycemia cost-effective?7. What are the optimal strategies for transition to outpatient care? 8. What are areas for future research? QUESTION 1: DOES IMPROVING GLYCEMIC CONTROL IMPROVE CLINICAL OUTCOMES FOR INPATIENTS WITHHYPERGLYCEMIA? -Hyperglycemia in hospitalized patients, irrespective of its cause, is unequivocally associated with adverse outcomes (5,6,18 -25).Hyperglycemia occurs in patients with known or undiagnosed diabetes, or it occurs during acute illness in those with previously normal glucose tolerance (termed "stress hyperglycemia") (8,26).Intervention directed at reducing blood glucose (BG) levels has resulted in improved outcomes in some, but not all, studies (5,18 -25).Several recent clinical trials in critically ill patients have reported no reduction in mortality from intensive treatment targeting near-euglycemia versus conventional management targeting BG Ͻ180 mg/dl (Ͻ10.0 mmol/l).Of considerable concern are reports of harm, with higher rates of severe hypoglycemia and even increased mortality (14) resulting from intensive glycemic control (12)(13)(14)16,27,28).This variability in results may be attributable to several factors, including differences in intravenous (IV) insulin treatment protocols and their implementation, glycemic targets, patient populations, methods for glucose monitoring, and insulin adjustment (12,29).The following section focuses primarily on results of recent studies with an RCT design that investigated patient outcomes with protocols targeting nearnormalization of BG levels.Readers are referred to a previous ACE position statement (9), an ACE/ADA consensus statement (11), and a technical review (8) for details related to earlier studies supporting inpatient glycemic management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Those without preexisting DM or stress hyperglycemia have a higher incidence of more postheart surgery complications.91,100–103”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [103]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Glucose targets >180 mg/dL or <110 mg/dL are no longer recommended in ICU patients.”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“and the BG targets used in this study were lower than glycemic targets recently recommended by the AACE and ADA inpatient glycemic control task force.25”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“Many guidelines that apply to hospitalized adults with hyperglycemia can probably be extrapolated to older adults130, 131.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Nevertheless, recent attempts to achieve tight glycemic control either have not reduced or have actually increased mortality in multicenter trials and clearly led to higher rates of hypoglycemia (13,14,16).”
BackgroundInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 5×
“The higher rates of severe hypoglycemia associated with intensive insulin therapy (12–14,16,27,28) raise the possibility that serious adverse events in the subgroup of patients experiencing hypoglycemia offset, at least in part, any benefit derived from strict glycemic control in the much larger subgroup of patients w…”
BackgroundInfluentialHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationCapes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Bates, D. W. (1998) · JAMA · doi:10.1001/jama.280.15.1311 · Cited by 2,107
The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital
Forster, A. J., Murff, H. J., Peterson, J. F., Gandhi, T. K., & Bates, D. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00007 · Cited by 1,886 · cited 1×
“Medication errors and adverse drug events have been linked to poor communication of instructions to the patient at the time of discharge (156,157).”
Background
Research works printed but not linked: 5
- 28. Devos P, Preiser JC, Me ´lot C, et al. Im- pact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the GluControl study (Abstract). Intensive Care Med 2007;33:S189
- 87. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(Suppl. 1):1-68
- 93. DiNardo M, Donihi AC, DeVita M, et al. A nurse directed protocol for recogni- tion and treatment of hypoglycemia in hospitalized patients. Pract Diabetol 2005;22:37-40
- 97. Donihi AC, Rea RS, Mihalko MA, et al. Comparison of different methods of transitioning MICU patients from intra- venous to subcutaneous insulin (Ab- stract). Diabetes 2007;57:A542
- 117. Reider J, Lin H, Dinardo M, et al. Efficacy of a guideline for treatment of corticoste- roid related hyperglycemia in the hospi- tal (Abstract). Diabetes 2008;57:A574 120.
Cited by
Items 901–1,000 of 1,001
Jackson, B., & Grubbs, L. M. (2013) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12033 · Cited by 5
Common Endocrinopathies in the Pediatric Intensive Care Unit
Ulate, K. P., & Zimmerman, J. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-07307-3.10077-1 · Cited by 5
Glycaemic control in intensive care: Everything in moderation
Devanesan, A., Lloyd, J., Samad, H., & Saha, S. (2016) · Journal of the Intensive Care Society · doi:10.1177/1751143716644455 · Cited by 5
Hospital Diabetes: Why Quality of Care Matters to Both Patients and Hospitals
Klonoff, D. C. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500101 · Cited by 5
Pichardo-Lowden, A. R. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820982661 · Cited by 5
“16(3) 771 –774 © 2021 Diabetes Technology Society Article reuse guidelines: sagepub.”
BackgroundMekonnen, G. A., & Abegaz, T. M. (2019) · doi:10.21203/rs.2.18079/v1 · Cited by 5
Mader, J. K., Motschnig, M., Theiler-Schwetz, V., Eibel-Reisz, K., Reisinger, A. C., Lackner, B., Augustin, T., Eller, P., & Mirth, C. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0082 · Cited by 4
Tu, X., Shi, C., Jiang, J., Lü, X., Li, F., Shi, X., Li, Q., & Wang, L. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03901-9 · Cited by 4
“…(1) whether they accounted for baseline glycemic status (HbA1c), which exhibits substantial variation between diabetic and non-diabetic populations, and (2) whether they employed the standardized glucose threshold of 7.8 mmol/L as defined by the American Diabetes Association (ADA) guidelines [64].”
InfluentialHyperglycemia in Critically Ill Patients: Current Approaches and Management Strategies
Daina, M. D., Vesa, C. M., Ghitea, T. C., Iova, C. F., Bontea, M. G., László, F., & Daina, C. M. (2026) · In Vivo · doi:10.21873/invivo.14223 · Cited by 4
Endocrinological aspects of managing patients after total duodenopancreatectomy
Lebedeva, A. N., & Vishnevsky, V. A. (2020) · Annaly khirurgicheskoy gepatologii = Annals of HPB surgery · doi:10.16931/1995-5464.2020396-111 · Cited by 4
Diabetes in all hospitalized cases in Germany 2015–2019 and impact of the first COVID-19 year 2020
Auzanneau, M., Eckert, A. J., Fritsche, A., Heni, M., Icks, A., Mueller‐Stierlin, A. S., Dugic, A., Risse, A., Lanzinger, S., & Holl, R. W. (2023) · Endocrine Connections · doi:10.1530/ec-22-0475 · Cited by 4
Basit, K. A., Bhowmik, B., & Majumdar, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22106-4.00005-x · Cited by 4
Quiñones, A. R., Hwang, J. H., Huguet, N., Madlock‐Brown, C., Marino, M., Voss, R., Garven, C., & Dorr, D. A. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09457-y · Cited by 4
Abusamaan, M. S., Fesseha, B., Kim, H. N., Reyes-DeJesus, D., Langan, S. J., Niessen, T. M., & Mathioudakis, N. N. (2020) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2020.100220 · Cited by 4
Glucose fluctuations and hypoglycemia as new cardiovascular risk factors in diabetes
Catargi, B., & Gerbaud, É. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.03.001 · Cited by 4
Hyperglycemia associated with parenteral nutrition in noncritical patients
Pérez‐Cruz, E., Ramón, P., & Alberto, M.-M. F. (2020) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2020.200114 · Cited by 4
Insulin Use and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Graft Surgery
Ranney, D. N., Williams, J. B., Albrecht, Á., Li, S., Kalil, R. A. K., Peterson, E. D., & Lópes, R. D. (2020) · Brazilian Journal of Cardiovascular Surgery · doi:10.21470/1678-9741-2019-0347 · Cited by 4
“Regardless, hyperglycemia has been associated with poor clinical outcomes in critically ill patients[4,21].”
BackgroundArias-Amaya, A. M., Bueno, R. C., Rangel-Rivera, D. A., & Pinto-Arias, A. J. (2020) · Revista Médicas UIS · doi:10.18273/revmed.v33n2-2020006 · Cited by 4
Diabetes mellitus in der Anästhesie – optimale perioperative Blutzuckerkontrolle
Alscher, F., Friesenhahn‐Ochs, B., & Hüppe, T. (2021) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-1154-6944 · Cited by 4
“erhalten, empfehlen wir– in Anlehnung an das aktualisierte „Yale-Protokoll“ [25] und das Konsensus-Schreiben der „American Association of Clinical Endocrinologists & American Diabetes Association“ [26] – Blutzuckerzielwerte von 125–180mg/dl.”
BackgroundInfluentialZeitoun, M. H., Abdel-Rahim, A., Hasanin, M. M., Hadidi, A. S. E., & Shahin, W. A. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.03.024 · Cited by 4
Rahimpour, F., Nejati, M., Moghaddas, A., Farsaei, S., & Feizi, A. (2023) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_45_23 · Cited by 4
“[28] After NICE-SUGAR, various approaches have been proposed to reduce IVI-associated hypoglycemia, including targeting higher blood glucose levels, more frequent blood glucose measurements, and increased caloric intake.”
MethodSardu, C., Marfella, L. V., Giordano, V., Lepre, C. C., D’Amico, G., Volpicelli, M., Contaldi, C., Galiero, R., Caturano, A., Casolaro, F., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1402782 · Cited by 4
Hypoglycaemia in inpatients with diabetes on nasogastric feeding
Vindedzis, S. A., Marsh, B., Sherriff, J. L., & Stanton, K. G. (2014) · Practical Diabetes · doi:10.1002/pdi.1824 · Cited by 4
Nya‐Ngatchou, J. J., Corl, D. E., Onstad, S., Yin, T. S., Tylee, T. S., Suhr, L. D., Thompson, R. E., & Wisse, B. E. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2575 · Cited by 4
“Although glycaemic control guidelines in ICU patients remain debated [10], many institutions agree that minimizing rates of hypoglycaemia in ICU patients is an important quality measure [11].”
BackgroundManaging hospitalized hemodialysis patients: A guide for the non-nephrologist
Saeed, F., & Wong, L. P. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1077094 · Cited by 4
“Glycemic targets ranging from 140 to 180 mg/dL are generally accepted in non-critically ill, hospitalized patients [10].”
BackgroundMartínez‐Brocca, M. A., Morales, C., Rodríguez-Ortega, P., Aguilera, B., Montes, C., Colomo, N., Piédrola, G., Méndez-Muros, M., Serrano, I., de Adana, M. S. R., et al. (2014) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.09.006 · Cited by 4
Interns’ viewpoints and knowledge about management of hyperglycemia in the hospital setting
Biagetti, B., Ciudin, A., Portela, M., Dalama, B., & Mesa, J. (2012) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2012.08.010 · Cited by 4
Harris, S. A., Nisly, S. A., Aykroyd, L., Carroll, J. C., Ulmer, B. J., Waddell, M., Flanders, S. J., & Juneja, R. (2013) · Advances in Diabetes and Metabolism · doi:10.13189/adm.2013.010106 · Cited by 4
Evaluation of an adult insulin infusion protocol at an academic medical center.
Petrov, K. I., Burns, T. L., & Drincic, A. (2012) · Europe PMC (PubMed Central) · Cited by 4
Schiller, F. (2013) · Cited by 4
Managing diabetes in hospitalized patients with chronic kidney disease
Iyer, S. N., & Tanenberg, R. J. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83a.14189 · Cited by 4
Perioperatives Management von Menschen mit Diabetes bei elektiven Eingriffen: Teil 1
Landgraf, R., Klauß, V., Middeke, M., Tretter, F., & Koscielny, J. (2017) · Der Diabetologe · doi:10.1007/s11428-017-0202-1 · Cited by 4
“Viele der potenziellen Komplikationen lassen sich durch eine strukturierte Betreuung in den verschiedenen Phasen des perioperativen Managements vermeiden [4, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23].”
Lotfy, M. A., & Shama, A. A. A. (2022) · Egyptian Journal of Anaesthesia · doi:10.1080/11101849.2022.2060636 · Cited by 4
Klapproth, S., Meyer, L., Kniep, H. C., Bechstein, M., Kyselyova, A. A., Hanning, U. M. P., Schön, G., Rimmele, D. L., Fiehler, J., & Broocks, G. (2023) · European Journal of Neurology · doi:10.1111/ene.16166 · Cited by 4
“Elevated BGL was defined as ≥140 mg/dL accord - ing to the current guidelines of the Centers for Disease Control and Prevention [ 17, 18 ].”
MethodButala, N. M., Johnson, B. K., Dziura, J. D., Reynolds, J. S., Bozzo, J., Balcezak, T. J., Inzucchi, S. E., & Horwitz, L. I. (2015) · Journal of Hospital Medicine · doi:10.1002/jhm.2321 · Cited by 4
“Consequently, less stringent glycemic targets are now recommended.(17) Nonetheless, hospitals are being held *Address for correspondence and reprint requests: Leora Horwitz, MD, Department of Population Health, 550 First Ave.”
BackgroundSelf-citationGuía Nacional de Consenso para el Diagnóstico y Tratamiento de las Emergencias Hiperglucémicas
Assef, V. J. C., López, A. C., & Marichal, I. I. (2015) · MediCiego · Cited by 4
[Hyperglycemia in acute coronary syndrome: multidisciplinary scientific report].
Blanco, P., Benzadón, M., Arazi, H. C., Duronto, E., Higa, C. C., González, M. Á. V., & Mele, E. F. (2012) · PubMed · Cited by 4
Martínez‐Brocca, M. A., Morales, C., Rodríguez-Ortega, P., González-Aguilera, B., Montes, C., Colomo, N., Piédrola, G., Méndez-Muros, M., Serrano, I., de Adana, M. S. R., et al. (2015) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2015.02.002 · Cited by 4
Chen, Y., Kao, S. L., Tai, E. S., Wee, H. L., Khoo, E. Y. H., Ning, Y., Salloway, M. K., Deng, X., & Tan, C. S. (2016) · BMC Medical Research Methodology · doi:10.1186/s12874-016-0142-2 · Cited by 4
“BG monitoring is performed every 30 min to 2 hourly, if a patient is on an intravenous insulin infusion [1–4].”
BackgroundKesavadev, J., Jain, S. M., Muruganathan, A., & Das, A. K. (2014) · PubMed · Cited by 4
Wu, S., & Furutani, E. (2016) · Transactions of the Institute of Systems Control and Information Engineers · doi:10.5687/iscie.29.258 · Cited by 4
Wu, S., & Furutani, E. (2016) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2016.7591176 · Cited by 4
“0 mmol/L) is currently recommended by the American Association of Clinical Endocrinologists and American Diabetes Association [3].”
BackgroundInfluentialCombined Insulin and GLP-1 Receptor Agonists: Simplifying Treatment or Adding Obstacles?
Yang, T., Cutshall, B. T., Tatara, A. W., & Ruegger, M. C. (2018) · Journal of Pharmacy Practice · doi:10.1177/0897190017753041 · Cited by 4
Methodology for the analysis and comparison of protocols for glycaemic control in intensive care
Fernández‐Méndez, R., Rodríguez-Villar, S., Méndez, P. F., Windle, R. J., & Adams, G. G. (2018) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13047 · Cited by 4
Gür-Özmen, S., Güngör–Tunçer, Ö., & Krespi, Y. (2019) · Medicine · doi:10.1097/md.0000000000016212 · Cited by 4
“For hospitalized patients, hyperglycemia was defined as blood glucose values higher than 140mg/dL.([8]) The dependent variable bloodpressurewasdivided into 2 categories (bloodpressure≥140/ 90 mmHg and <140/90 mmHg) and the variable blood glucose was divided into 2 categories (≥140mg/dL and <140mg/dL).”
MethodСыволап, В. Д., & Kapshytar, N. I. (2019) · Pathologia · doi:10.14739/2310-1237.2019.1.166236 · Cited by 4
Zhu, Y., Yang, Y., Yang, M., Xia, W., Zhou, H., Zhu, X.-J., Tang, N., & Li, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230115 · Cited by 4
“8 mmol/L at any time during hospitalization [2, 10] and 2) age>18 years; the exclusion criteria were as follows: 1) ICU transfer during hospitalization and 2) poor compliance.”
BackgroundManagement of Patients with Diabetes in the Intensive Care Unit
Cieślak, J., Levin, A., & Beaulieu, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00215-6 · Cited by 4
Anesthesia management in a post Covid-19 obstetric patient-What we need to know
Bajwa, S. J. S., Sharma, R., Kurdi, M., Katikar, M. D., Bajwa, S., & Choudhary, R. (2022) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/joacp.joacp_550_21 · Cited by 4
Anesthesia in Liver Transplantation
Kanbak, M., Karagöz, A. H., & zmcgil, F. (2012) · InTech eBooks · doi:10.5772/28177 · Cited by 4
“Although transplant patients were not specifically mentioned, The American Association of Clinical Endocrinologists (AACE) and the American Diabetes Association (ADA) reported a consensus statement on glycemic control (Moghissi et al, 2009).”
BackgroundManagement of Hyperglycemia in Hospitalized Patients: Noncritical Care Setting
Pichardo-Lowden, A. R. (2014) · Frontiers in diabetes · doi:10.1159/000363468 · Cited by 4
Is There A “July Effect” for Inpatient Glycemic Control?
Nicolas, K., Raroque, S., Rowland, D. Y., & Chaiban, J. T. (2014) · Endocrine Practice · doi:10.4158/ep13406.cr · Cited by 4
Control glucémico en el hospital. ¿Por qué no mejora?
Pérez, A. (2012) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2012.01.014 · Cited by 4
Hyperglycemia in the intensive care unit: is insulin the only option?
Dungan, K. M. (2013) · Critical Care · doi:10.1186/cc13107 · Cited by 4
Evaluating an Insulin Infusion Protocol in an Acute Care Setting
Locke, C., McEuen, J. A., Felder, R. S., Lesselroth, B., Barrett, T. W., Stevens, B., & Pope, D. S. (2011) · Clinical Nurse Specialist · doi:10.1097/nur.0b013e3182299522 · Cited by 4
“In 2009, the AACE and the American Diabetes Association revised the 2006 consensus statement to recommend the use of a validated written or computerized insulin infusion protocol (IIP) for inpatient glucose control.(8)”
MethodHyperglycemia in Critical Illness
Weant, K. A., Bailey, A. M., & Baker, S. N. (2013) · Advanced Emergency Nursing Journal · doi:10.1097/tme.0b013e31829e5b96 · Cited by 4
“The American Association of Clinical Endocrinologists and the American Diabetes Association published a consensus statement on inpatient glycemic control in 2009 (Moghissi et al., 2009).”
BackgroundNyenwe, E. A. (2011) · BMJ Evidence-Based Medicine · doi:10.1136/ebm1413 · Cited by 4
Improving IV Insulin Administration in a Community Hospital
Magee, M. C. (2012) · Journal of Visualized Experiments · doi:10.3791/3705-v · Cited by 4
Montanier, N., Bernard, L., Lambert, C., Pereira, B., Desbiez, F., Terral, D., Abergel, A., Bohatier, J., Rosset, E., Schmidt, J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211425 · Cited by 4
Intravenous Bolus Insulin Delivery: Implications for Closed-Loop Control and Hospital Care
Hirsch, I. B. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0222 · Cited by 4
Self-citationFatores de risco para infecção do sítio cirúrgico em transplante de fígado: coorte histórica
Oliveira, R. A. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.7.2017.tde-17052017-125931 · Cited by 4
Tercer Consenso Argentino sobre Patologías endocrinológicas
Boquete, H. (2009) · Revista Argentina de Endocrinología y Metabolismo · Cited by 3
Lin, J., Zhang, J., Liang, B., Lin, J., Wang, N., Lin, J., & Huang, H. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01242-3 · Cited by 3
“Hyperglycemia affects millions of patients annually, increasing the risk of both infectious and noninfectious complications [1, 2], mortality rates [3, 4], hospital days, and costs [5].”
BackgroundPara, O., Valuparampil, J. B., Merilli, I., Caruso, L., Raza, A., Parenti, A., Angoli, C., Refaie, M. O. I., Onesto, M., Barbacci, L., et al. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-03866-x · Cited by 3
“…as elevated blood pressure episode occurring during the hospital stay according to ESH guidelines 2023 [28], infection of urinary trait; pneumonia; hyperglycemia defined as > 140 mg/ dL (7.8 mmol/L) by the American Association of Clinical Endocrinologists and the American Diabetes Association [29].”
InfluentialOlsen, M. T., Hjejle, S., Rasmussen, L. M., Klarskov, C. K., Lindegaard, B., Andersen, J. A., Gottlieb, H., Lunding, S., Nørgaard, K., Pedersen‐Bjergaard, U., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf137 · Cited by 3
“Among hospitalized patients, hyperglycemia, hypoglycemia, and high glycemic variability are associated with adverse outcomes, including increased in-hospital mortality, prolonged hospital stays, and higher rates of complications [1-6].”
Diabetic retinopathy classification using lightweight retinal features extraction from fundus images
Bhutnal, V. H., & Moparthi, N. R. (2025) · Multimedia Tools and Applications · doi:10.1007/s11042-025-21106-4 · Cited by 3
“The American Diabetes Association (ADA) advises screening type 1 diabetes patients three to five years after the start, and type 2 dia - betic patients one year [5 , 6 ].”
Daina, M. D., Ilea, C. D. N., Vesa, C. M., Venter, A. C., Bîrsan, S. D., Ghitea, T. C., Fehér, L., & Daina, C. M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062439 · Cited by 3
“Hyperglycemia on admission, wide glycemic variations and episodes of severe hypo or hyperglycemia are frequently associated with increased mortality, longer length of hospitalization and infectious complications [22–30].”
Use of Insulin in the Inpatient Setting: Need for Continued Use
Kumar, S., & Molitch, M. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1183-9 · Cited by 3
Tran, M. N. T., Dang, K. T., Lý, Đ. L., & Tran, N. Q. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01079-y · Cited by 3
Fragoso, L. V. C., de Araújo, M. F. M., Lobo, L. F. D. S., Schreen, D., Zanetti, M. L., & Damasceno, M. M. C. (2022) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2022ao6959 · Cited by 3
Toward better diabetes care: Exploration and implementation
Sheu, W. H. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.13978 · Cited by 3
Anesthesia for adults in outpatient surgery
Zaytsev, A. Y., Teplykh, B., Алиев, В. А., Boyarkov, A. V., Kuzovlev, A. N., Lapin, O. V., & Semenov, S. V. (2024) · Russian Journal of Anesthesiology and Reanimatology · doi:10.17116/anaesthesiology20240216 · Cited by 3
Rameshi, Y., Dashti‐Khavidaki, S., Rabizadeh, S., Alimadadi, M., Moradi, A., Kasraianfard, A., Jafarian, A., & Ahmadinejad, Z. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70107 · Cited by 3
“%) who experience hyperglycemia during hospitalisation are considered to have stress-induced or drug-induced hyperglycemia [42].”
Perez, M. E., Varga, L. I., Rose, C. M., & Gaughan, J. (2013) · Hospital Pharmacy · doi:10.1310/hpj4803-213 · Cited by 3
“In response to this new evidence, the American Association of Clinical Endocrinologists (AACE) and the American Diabetes Association (ADA) have published revised guidelines on inpatient glycemic control.(11)”
BackgroundGame, F. L. (2012) · Annals of The Royal College of Surgeons of England · doi:10.1308/003588412x13171221591655 · Cited by 3
Relationship Between Hyperglycemia and Heart Transplant Rejection
Mateo, R., Gupta, S., Wallia, A., Cameron, C. M., Schmidt, K., Oakes, D. J., Aleppo, G., Andrei, A., Wilcox, J. E., Grady, K. L., et al. (2015) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.09.063 · Cited by 3
Moghissi, E. S., Inzucchi, S. E., Mann, K. V., Byerly, B., Ermentrout, L., Juchniewicz, J. J., Ferareza, J. H., & Kirkwood, N. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1103191 · Cited by 3
“[5] According to major medical society guidelines,[2,15] the establishment and/or maintenance of glucose control in noncritically ill patients with known or newly diagnosed diabetes in the hospital is best managed with regularly scheduled subcutaneous insulin.”
BackgroundSelf-citationDurán, S., Rivas, M. A. P., & Pérez, A. (2016) · Cited by 3
Admission hyperglycemia in sepsis is associated with poor outcomes: where do we go from here?
Szumita, P. M., & Gilmore, J. F. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.05.17 · Cited by 3
“com recommend critically ill hospitalized patients using insulin therapy should be managed toward a goal glucose value between 140 and 180 mg/dL (6-9).”
BackgroundManagement of Hyperglycemia in Hospitalized Noncritical Patients
Mikhail, N. E. (2013) · Southern Medical Journal · doi:10.1097/smj.0b013e318287febe · Cited by 3
A Tight Glycemic Control Initiative in a Surgical Intensive Care Unit and Hospitalwide
Horst, H. M., Rubinfeld, I. S., Mlynarek, M. E., Brandt, M.-M., Boleski, G., Jordan, J., Gnam, G., & Conway, W. A. (2010) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(10)36045-4 · Cited by 3
Pathway for the Management of Hyperglycemia in the Cardiac Care Unit
Dehkordi, S. H. H., Albu, J., Aziz, E. F., & Herzog, E. (2017) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0000000000000112 · Cited by 3
Cantillo, A., Giraldo, G. C., & Castrillón, J. J. C. (2013) · Archivos de Medicina (Manizales) · doi:10.30554/archmed.12.2.6.2012 · Cited by 3
Atkinson, B., Corl, D. E., Pergamit, R. F., Weaver, K. W., Tylee, T. S., & Wisse, B. E. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.11.007 · Cited by 3
Kononova, Y. A., Abramyan, L., Derevitskii, I. V., & Babenko, A. Y. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13060997 · Cited by 3
Fagher, K., Ekström, E., Rystedt, J. L., Tingstedt, B., Andersson, B., & Löndahl, M. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02158-0 · Cited by 3
“…recommend targets for glucose levels in hospitalized patients with premeal and random glucose targets of < 7.8 mmol/l (< 140 mg/dl) and < 10 mmol/l (< 180 mg/ dl), respectively, for non-critically ill patients; and target ranges of 7.8–10 mmol/l (140–180 mg/dl) for critically ill patients [7, 8].”
BackgroundInfluentialIn‐Hospital Treatment and Surgery in People with Diabetes
Dhatariya, K., Newland‐Jones, P., & Patel, M. A. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch39 · Cited by 3
Morshed, A. A. M., Munn, Z., & Lockwood, C. S. (2014) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2014-1676 · Cited by 3
Tadıbı, V., & (MA), B. Z. (2012) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Bender, M., Smith, T. C., Thompson, J., Koucheki, A., & Holdy, K. E. (2015) · Journal of clinical outcomes management · Cited by 3
Othman, N. F. (2014) · Journal of Nephrology & Therapeutics · doi:10.4172/2161-0959.s1-005 · Cited by 3
“Aiming for the lowest effective steroid dose after transplantation decreased the risk of NODAT [48,51].”
BackgroundAmbulatory anesthesia: optimal perioperative management of the diabetic patient
Polderman, J. A. W., van Wilpe, R., Eshuis, J. H., Preckel, B., & Hermanides, J. (2016) · Ambulatory Anesthesia · doi:10.2147/aa.s102136 · Cited by 3
Diabetes Mellitus and Peripheral Vascular Disease
Freeby, M. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-158-5_3 · Cited by 3
Diseases of the Endocrine System
Akhtar, S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2787-6.00013-9 · Cited by 3
Wu, S., & Furutani, E. (2017) · IEEE Conference on Control Technology and Applications (CCTA) · doi:10.1109/ccta.2017.8062519 · Cited by 3
“No severe hypoglycemic episodes (BG < 40 mg/dL [19]) is observed in our simulations.”
BackgroundNeuroanesthesia and Monitoring for Cranial and Complex Spinal Surgery
Rajan, S., & Sharma, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-43140-8.00005-6 · Cited by 3
Cabrera, A. A., Aguirre-Quispe, W., Instituto Nacional de Salud. Lima, P., Alva‐Díaz, C., García-Mostajo, J. A., & Mansilla, A. A. Z. (2018) · Horizonte Médico (Lima) · doi:10.24265/horizmed.2018.v18n2.06 · Cited by 3
“Aunque existen distintas organizaciones que han elaborado directrices a seguir sobre los objetivos de glicemia tanto en el ámbito hospitalario como ambulatorio (9,10), la Asociación Americana de Diabetes establece como objetivo de adecuado control glicémico en el área extra hospitalaria a una glicemia ≤ 130mg/dL en ay…”
BackgroundGoswami, G., Scheinberg, N., Schechter, C. B., Ruocco, V., & Davis, N. J. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0497 · Cited by 3
Eating and Glycemic Control Among Critically Ill Patients Receiving Continuous Intravenous Insulin
Miller, E. E., Lalla, M., Zaidi, A., Elgash, M., Zhao, H., & Rubin, D. J. (2019) · Endocrine Practice · doi:10.4158/ep-2019-0095 · Cited by 3
Hiperglucemia inducida por glucocorticoides en el paciente hospitalizado: enfoque y manejo
Lopera, R. T., Barrera, A. F. C., & Rojas, W. (2019) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.6.1.469 · Cited by 3
Metadata
- Authors
- Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E.
- Affiliations
- University of California, Los Angeles (US)
- University of Pittsburgh (US)
- University of California San Diego (US)
- University of Missouri–Kansas City (US)
- University of Washington (US)
- Yale New Haven Hospital (US)
- Department of Medicine, Physiology and Biophysics, Division of Clinical and Molecular Endocrinology, Case Western Reserve University, Cleveland, Ohio;
- American Diabetes Association (US)
- Emory University (US)
- Corresponding author
- Moghissi, Etie S.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-06-01
- Volume
- 32
- Issue
- 6
- Pages
- 1119-1131
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2681039
- OpenAlex
- W2149347361
- Cited by
- 1,444
- References
- 171
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 78 · 2023: 63 · 2022: 66 · 2021: 83 · 2020: 98 · 2019: 67 · 2018: 84 · 2017: 85 · 2016: 101 · 2015: 105 · 2014: 134 · 2013: 89 · 2012: 131
- FWCI
- 76.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- inpatient glycemic control, hyperglycemia, stress hyperglycemia, intensive insulin therapy, hypoglycemia, critically ill patients, hospitalized patients, transition to outpatient care, cost-effectiveness, glucose monitoring, clinical outcomes
- MeSH terms
- Blood Glucose, Consensus Statements as Topic, Diabetes Mellitus, Endocrinology, Humans, Hyperglycemia, Inpatients, Societies, Medical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.